UNICA IRIS Institutional Research Information System

PANI, FABIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 78.463
NA - Nord America 1.896
AS - Asia 468
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 5
AF - Africa 1
OC - Oceania 1
Totale 80.841
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 77.813
US - Stati Uniti d'America 1.876
CN - Cina 290
UA - Ucraina 165
SE - Svezia 143
SG - Singapore 91
FR - Francia 82
DE - Germania 68
GB - Regno Unito 66
FI - Finlandia 42
KR - Corea 25
NL - Olanda 18
CA - Canada 17
VN - Vietnam 16
BE - Belgio 15
IN - India 13
IR - Iran 11
PL - Polonia 11
RU - Federazione Russa 10
TR - Turchia 9
EU - Europa 7
CH - Svizzera 5
EC - Ecuador 4
LT - Lituania 4
AL - Albania 3
ES - Italia 3
IQ - Iraq 3
JP - Giappone 3
RO - Romania 3
BG - Bulgaria 2
HR - Croazia 2
ID - Indonesia 2
IE - Irlanda 2
IL - Israele 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BR - Brasile 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
EG - Egitto 1
KZ - Kazakistan 1
MX - Messico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
Totale 80.841
Salva come PNG Salva come JPEG
Città #
Cagliari 72.982
Uta 1.108
Milan 285
Rome 285
Chandler 193
Woodbridge 172
Fairfield 142
Nyköping 124
Houston 109
Dearborn 105
Ashburn 103
Boardman 91
Wilmington 84
Ann Arbor 72
Naples 70
Seattle 68
New York 63
Bologna 57
Cambridge 56
Shanghai 54
Florence 50
Singapore 48
Jacksonville 43
Palermo 37
Nanjing 36
Santa Clara 36
Turin 36
Bari 33
Catania 33
Helsinki 33
Boston 31
Beijing 26
Genoa 24
Seoul 24
Padova 20
San Diego 18
San Mateo 18
Torino 18
Atlanta 17
Parma 17
Dong Ket 16
Avellino 15
Guangzhou 15
Hebei 15
Pescara 15
Redwood City 15
Toronto 15
Zhengzhou 15
Jiaxing 14
Reggio Calabria 14
Shenyang 14
Mountain View 13
Nanchang 13
Brescia 12
London 12
Monza 12
Messina 11
Perugia 11
Salerno 11
Verona 11
Baltimore 10
Foggia 10
Genova 10
Montecchio Maggiore 10
Rimini 10
Varazze 10
Bergamo 9
Brussels 9
Los Angeles 9
Sassari 9
Segrate 9
Changsha 8
Leawood 8
Lissone 8
Modena 8
Munich 8
Orange 8
Udine 8
Como 7
Giugliano in Campania 7
Livorno 7
Napoli 7
Nichelino 7
Norwalk 7
Redmond 7
Tianjin 7
Angri 6
Augusta 6
Hangzhou 6
Kunming 6
Lamezia Terme 6
Lucca 6
Novara 6
Oristano 6
Piacenza 6
Pisa 6
San Giuliano Milanese 6
Taranto 6
Wuhan 6
Altopascio 5
Totale 77.390
Salva come PNG Salva come JPEG
Nome #
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 4.802
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.774
Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells 3.275
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 3.051
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 3.027
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.876
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.848
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.820
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 2.805
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.739
Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells 2.695
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.571
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.553
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.512
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.373
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.362
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.337
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.273
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.237
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.235
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.154
The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience 2.150
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.111
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.023
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 2.008
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 1.922
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 1.921
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 1.910
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.865
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.836
Thyroid dysfunction and ultrasonography features in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Preliminary results from a prospective cohort study. 1.268
Embolization of iliac metastasis during lenvatinib treatment in patient with advanced Hürthle cell thyroid carcinoma 1.132
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome 727
Caratteristiche cliniche, endocrine, e metaboliche di donne non obese affette da sindrome dell'ovaio policistico (PCOS) dopo sei cicli di trattamento con la formulazione contraccettiva estroprogestinica orale monofasica contenente 30 mcg di etinilestradiolo (EE) e 2 mg di clormadinone acetato (CMA) 719
CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients. 90
Totale 81.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.109 0 0 0 0 0 5.615 2.644 468 290 377 247 468
2020/202124.462 680 970 879 7.417 4.632 2.818 1.479 1.421 721 1.424 1.253 768
2021/20224.549 598 367 245 458 349 338 287 239 444 437 390 397
2022/20236.015 560 912 896 460 414 375 306 419 424 369 574 306
2023/20246.317 405 242 260 391 568 958 981 569 306 402 624 611
2024/20258.755 2.590 2.943 1.199 1.020 559 444 0 0 0 0 0 0
Totale 81.001